Discussion
Comment receiving replies
Replies to "Rpacheco23: you also may want to look at the MRIdian radiation machine from viewray (viewray.com).5 treatments..."
Prostate Cancer | Last Active: Jul 3, 2023 | Replies (8)
Comment receiving replies
Replies to "Rpacheco23: you also may want to look at the MRIdian radiation machine from viewray (viewray.com).5 treatments..."
https://www.pcf.org/c/breaking-news-fda-approves-talazoparib-enzalutamide-for-metastatic-castration-resistant-prostate-cancer/
Breaking News: FDA Approves Talazoparib + Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
The FDA has approved a new medication, talazoparib, in combination with enzalutamide for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have mutations in certain genes involved in DNA repair. This means that patients with mCRPC (prostate cancer that has spread beyond the prostate and continues to grow despite low testosterone) have an additional treatment option.